What are the uses and dosages of acetazolamide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetazolamide: Uses and Dosages

Acetazolamide is a carbonic anhydrase inhibitor with multiple therapeutic applications including glaucoma (250 mg-1 g daily), epilepsy (8-30 mg/kg daily), altitude sickness prevention (125-250 mg twice daily), idiopathic intracranial hypertension, and as a diuretic for heart failure (250-375 mg once daily). 1, 2

Primary Indications and Dosing

Glaucoma

  • Dosage: 250 mg to 1 g per 24 hours, usually in divided doses for amounts over 250 mg 2
  • For acute congestive (closed-angle) glaucoma: 250 mg every four hours, or initial dose of 500 mg followed by 125-250 mg every four hours 2
  • Intravenous therapy may be used for rapid relief of ocular tension in acute cases 2
  • Works synergistically with miotics or mydriatics 2

Epilepsy

  • Dosage: 8-30 mg/kg daily in divided doses 2
  • Optimal range: 375-1000 mg daily 2
  • When adding to existing anticonvulsants, start with 250 mg once daily and increase gradually 2
  • Most effective for petit mal epilepsy in children, but also useful for other seizure types 2, 3

Altitude Sickness Prevention

  • Dosage: 125-250 mg twice daily, starting 24 hours before ascent 1
  • Reduces risk of acute mountain sickness by 48% compared to placebo 4
  • 250 mg/day has similar efficacy to higher doses with potentially fewer side effects 4, 5

Heart Failure/Edema

  • Dosage: 250-375 mg once daily in the morning (5 mg/kg) 2
  • Best results when given on alternate days or for two days alternating with a day of rest 2
  • Does not eliminate need for other therapy such as digitalis, bed rest, and salt restriction 2

Idiopathic Intracranial Hypertension

  • Used to reduce cerebrospinal fluid production and intracranial pressure 1, 6
  • Helps avoid invasive procedures in patients with CSF leaks or elevated ICP 6

Administration and Pharmacokinetics

  • Primarily administered orally; intravenous route preferred when available; intramuscular administration not recommended 2
  • Plasma half-life: 4-8 hours, though pharmacologic effects last longer 6
  • Highly protein-bound and primarily eliminated by kidneys 6
  • For patients with creatinine clearance <50 mL/min, administration should not be more frequent than every 12 hours 6

Contraindications and Precautions

  • Contraindicated in patients with:
    • Sulfa allergy
    • Severe hepatic disease
    • Severe renal disease
    • Adrenocortical insufficiency
    • Hyperchloremic acidosis 1

Monitoring and Side Effects

  • Monitor serum electrolytes, renal function, acid-base status, and clinical response 1
  • Common side effects:
    • Paresthesias
    • Vertigo
    • Altered taste
    • Increased urination
    • Dizziness
    • Metabolic acidosis 1
  • More serious adverse effects:
    • Kidney stones
    • Lethargy
    • Appetite suppression
    • Rare blood dyscrasias 3
  • Avoid combining with other diuretics due to increased risk of dehydration and electrolyte imbalances 1
  • Limit caffeine intake to avoid worsening side effects and impact on treatment efficacy 1

Special Considerations

  • Partial tolerance may develop to antiepileptic activity 3
  • For altitude sickness, should be combined with proper acclimatization strategies:
    • Gradual ascent (300-600m/day above 2500m)
    • Rest days
    • Adequate hydration
    • Avoiding overexertion 1
  • Women may have higher risk of acute mountain sickness; pre-acclimatization and slow ascent particularly important 1

Acetazolamide remains a valuable medication across multiple therapeutic areas, with dosing regimens that should be tailored to the specific indication and patient characteristics.

References

Guideline

Acetazolamide Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acetazolamide in the treatment of seizures.

The Annals of pharmacotherapy, 1996

Research

Evaluating off-label uses of acetazolamide.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.